Back to User profile » Dr Hang Li
Papers published by Dr Hang Li:
NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Huang Q, Cao H, Yao Q, Zhou X, Li H, Bai Q, Hu H
ImmunoTargets and Therapy 2023, 12:165-173
Published Date: 5 December 2023
The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations
Zheng DF, Wang R, Zhang Y, Pan YJ, Cheng XH, Cheng C, Zheng SB, Li H, Gong RX, Li Y, Shen XX, Sun YH, Chen HQ
OncoTargets and Therapy 2016, 9:833-843
Published Date: 22 February 2016
Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma
Cai D, Li H, Wang R, Li Y, Pan YJ, Hu HC, Zhang Y, Gong RX, Pan B, Sun YH, Chen HQ
OncoTargets and Therapy 2014, 7:2127-2132
Published Date: 18 November 2014
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma
Hu H, Pan Y, Li Y, Wang L, Wang R, Zhang Y, Li H, Ye T, Zhang Y, Luo X, Shao L, Sun Z, Cai D, Xu J, Lu Q, Deng Y, Shen L, Ji H, Sun Y, Chen H
OncoTargets and Therapy 2014, 7:1423-1437
Published Date: 13 August 2014
Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
Zhang Y, Wang L, Li Y, Pan Y, Wang R, Hu H, Li H, Luo X, Ye T, Sun Y, Chen H
OncoTargets and Therapy 2014, 7:567-573
Published Date: 12 April 2014
Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
Li H, Hu H, Wang R, Pan Y, Wang L, Li Y, Zhang Y, Ye T, Zhang Y, Li B, Shen L, Sun Y, Chen H
OncoTargets and Therapy 2014, 7:513-524
Published Date: 3 April 2014